How immune-response profiling can improve sepsis outcomes

Tuesday, September 28, 10:00 - 10:20 a.m.
Exhibit Hall, Theater 2
Supported by Inflammatix, Inc.


Quickly identifying whether a patient has an infection, and if that infection is likely to progress to sepsis, are critical to the evaluation of patients in the emergency department, where minutes matter. Diagnostics play a key role in the ED clinician’s toolkit. However, current tools overly rely on measuring bacteremia, thereby missing early windows for intervention, as the majority of pathogens that cause infection are not circulating in the blood. We need better solutions in the ED that improve patient outcomes. This presentation will characterize the challenges of identifying sepsis in the ED and discuss how measuring the patient’s immune response to pathogens may represent a better approach.


After attending this session, participants will be able to:

  • Understand the shortcomings of current ED diagnostic tools.
  • Understand the key role host immune response diagnostics play in sepsis diagnosis, both now and in the future.


Tim Sweeney, MD, PhD
Co-Founder and CEO of Inflammatix
Inflammatix, Inc.
Burlingame, CA